Harvard Bioscience

HBIONasdaq United States Industrials Biotechnology: Laboratory Analytical Instruments

Market cap

$39.514 M

$8.68 +0.81%

Close of 6 Nov 2026

As of 6 Nov 2026, Harvard Bioscience (HBIO) has a market capitalization of $39.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$86.5M

#2530 by revenue

Earnings

-$56.7M

Loss-making

Shares outstanding

4,552,305

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →

#14QuanterixQTRX$130.1M
#15SeerSEER$90.5M
#16Harvard BioscienceHBIO$39.5M
#17PrecipioPRPO$34.0M
#18Rapid Micro BiosystemsRPID$31.2M

What if Harvard Bioscience were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,202,764

Per share 714,604× higher

Bitcoin $1.53T

$335,620.77

Per share 38,666× higher

Apple $5.02T

$1,101,812

Per share 126,937× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Harvard Bioscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.